Polymer-drug conjugates as nanomedicine: a review

References

• Danhier, F.; Feron, O.; Préat, V. To Exploit the Tumor Microenvironment: passive and Active Tumor Targeting of Nanocarriers for anti-Cancer Drug Delivery. J. Control Release. 2010, 148, 135–146.
   PubMed Web of Science ®Google Scholar
• Khan, J.; Alexander, A.; Saraf, S.; Saraf, S. Exploring the Role of Polymeric Conjugates Toward Anti-Cancer Drug Delivery: Current Trends and Future Projections. Int. J. Pharm. 2018, 548, 500–514.
   PubMed Web of Science ®Google Scholar
• Bhoskar, M.; Patil, P. Development and Evaluation of Paclitaxel Loaded Nanoparticles Using 24 Factorial Design. Int.J.Curr.Pharm.Res. 2015, 7, 64–72.
   Google Scholar
• Xu, H.; Ma, H.; Yang, P.; Zhang, X.; Wu, X.; Yin, W.; Wang, H.; Xu, D. Targeted Polymer-Drug Conjugates: current Progress and Future Perspective. Colloid Surface B. 2015, 136, 729–734.
   PubMed Web of Science ®Google Scholar
• Ulbrich, K.; Holá, K.; Šubr, V.; Bakandritsos, A.; Tuček, J.; Zbořil, R. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chem. Rev. 2016, 116, 5338–5431.
   PubMed Web of Science ®Google Scholar
• D'souza, A. A.; Devarajan, P. V. Asialoglycoprotein Receptor Mediated Hepatocyte Targeting—Strategies and Applications. J. Control Release. 2015, 203, 126–139.
   PubMed Web of Science ®Google Scholar
• Dahms, N. M.; Lobel, P.; Kornfeld, S. Mannose 6-Phosphate Receptors and Lysosomal Enzyme Targeting. J. Biol. Chem. 1989, 264, 12115–12118.
   PubMed Web of Science ®Google Scholar
• Le Droumaguet, B.; Nicolas, J.; Brambilla, D.; Mura, S.; Maksimenko, A.; De Kimpe, L.; Salvati, E.; Zona, C.; Airoldi, C.; Canovi, M.; et al. Versatile and Efficient Targeting Using a Single Nanoparticulate Platform: application to Cancer and Alzheimer’s Disease. ACS Nano. 2012, 6, 5866–5879.
   PubMed Web of Science ®Google Scholar
• Sudimack, J.; Lee, R. J. Targeted Drug Delivery via the Folate Receptor. Adv. Drug Deliv. Rev. 2000, 41, 147–162.
   PubMed Web of Science ®Google Scholar
• Garanger, E.; Boturyn, D.; Dumy, P. Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers. Acamc. 2007, 7, 552–558.
   Web of Science ®Google Scholar
• Vannucci, L.; Falvo, E.; Fornara, M.; Di Micco, P.; Benada, O.; Krizan, J.; Svoboda, J.; Hulikova-Capkova, K.; Morea, V.; Boffi, A.; Ceci, P. Selective Targeting of Melanoma by PEG-Masked Protein-Based Multifunctional Nanoparticles. Int.J. Nanomed. 2012, 7, 1489.
   PubMed Web of Science ®Google Scholar
• Mendelsohn, J.; Baselga, J. The EGF Receptor Family as Targets for Cancer Therapy. Oncogene. 2000, 19, 6550.
   PubMed Web of Science ®Google Scholar
• Suresh, T.; Lee, L. X.; Joshi, J.; Barta, S. K. New Antibody Approaches to Lymphoma Therapy. J. Hematol. Oncol. 2014, 7, 58.
   PubMed Web of Science ®Google Scholar
• Mollgard, L.; Rebello, P.; Hale, G.; Waldmann, H.; Mellstedt, H.; Osterborg, A.; Lundin, J.; Kimby, E.; Bjorkholm, M.; Broliden, P. A.; et al. Phase II Trial of Subcutaneous anti-CD52 Monoclonal Antibody. Blood. 2002, 100, 768–773.
   Google Scholar
• Jain, R. K.; Duda, D. G.; Clark, J. W.; Loeffler, J. S. Lessons from Phase III Clinical Trials on anti-VEGF Therapy for Cancer. Nat. Rev. Clin. Oncol. 2006, 3, 24.
   Web of Science ®Google Scholar
• Tai, W.; Mahato, R.; Cheng, K. The Role of HER2 in Cancer Therapy and Targeted Drug Delivery. J. Control. Release. 2010, 146, 264–275.
   PubMed Web of Science ®Google Scholar
• Daniels, T. R.; Delgado, T.; Rodriguez, J. A.; Helguera, G.; Penichet, M. L. The Transferrin Receptor Part I: Biology and Targeting with Cytotoxic Antibodies for the Treatment of Cancer. Clin Immunol. 2006, 121, 144–158.
   PubMed Web of Science ®Google Scholar
• Daniels, T. R.; Bernabeu, E.; Rodríguez, J. A.; Patel, S.; Kozman, M.; Chiappetta, D. A.; Holler, E.; Ljubimova, J. Y.; Helguera, G.; Penichet, M. L. The Transferrin Receptor and the Targeted Delivery of Therapeutic Agents Against Cancer. BBA. 2012, 1820, 291–317.
   PubMed Web of Science ®Google Scholar
• Kuan, C. T.; Wikstrand, C. J.; Archer, G.; Beers, R.; Pastan, I.; Zalutsky, M. R.; Bigner, D. D. Increased Binding Affinity Enhances Targeting of Glioma Xenografts by EGFRvIII‐Specific scFv. Int. J. Cancer. 2000, 88, 962–969.
   PubMed Web of Science ®Google Scholar
• Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Nanomedicine: Current Status and Future Prospects. FASEB. 2005, 19, 311–330.
   PubMed Web of Science ®Google Scholar
• Langer, R. Drug Delivery and Targeting. Nature-London. 1998, 5, 2551–2556.
   Google Scholar
• Matsumura, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res. 1986, 46, 6387–6392.
   PubMed Web of Science ®Google Scholar
• Hawkins, M. J.; Soon-Shiong, P.; Desai, N. Protein Nanoparticles as Drug Carriers in Clinical Medicine. Adv. Drug Deliv, Rev. 2008, 60, 876–885.
   PubMed Web of Science ®Google Scholar
• Gabizon, A.; Shmeeda, H.; Barenholz, Y. Pharmacokinetics of Pegylated Liposomal Doxorubicin. Clin Pharmacokinet. 2003, 42, 419–436.
   PubMed Web of Science ®Google Scholar
• Patil, P.; Mahajan, H. S. A Review on Polymer Drug Conjugate‒What, Why and How. IJPSR. 2015, 6, 4611–4621.
   Google Scholar
• Feng, Q.; Tong, R. Anticancer Nano Particulate Polymer‐Drug Conjugate. Bioeng. Transl. Med. 2016, 1, 277–296.
   PubMed Web of Science ®Google Scholar
• Vogus, D. R.; Krishnan, V.; Mitragotri, S. A Review on Engineering Polymer Drug Conjugates to Improve Combination Chemotherapy. Curr Opin Colloid Interface Sci. 2017, 31, 75–85.
   Web of Science ®Google Scholar
• Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic Therapy. JNCI. 1998, 90, 889–905.
   PubMed Web of Science ®Google Scholar
• Ochsner, M. Photophysical and Photobiological Processes in the Photodynamic Therapy of Tumours. J. Photoche Photobio. B. 1997, 39, 1–18.
   PubMed Web of Science ®Google Scholar
• McCarthy, J. R.; Perez, J. M.; Brückner, C.; Weissleder, R. Polymeric Nanoparticle Preparation That Eradicates Tumors. Nano Lett. 2005, 5, 2552–2556.
   PubMed Web of Science ®Google Scholar
• Jiang, H.; Taranekar, P.; Reynolds, J. R.; Schanze, K. S. Conjugated Polyelectrolytes: Synthesis, Photophysics, and Applications. Angew. Chem. Int. Ed. 2009, 48, 4300–4316.
   PubMed Web of Science ®Google Scholar
• Lu, L.; Rininsland, F. H.; Wittenburg, S. K.; Achyuthan, K. E.; McBranch, D. W.; Whitten, D. G. Biocidal Activity of a Light-Absorbing Fluorescent Conjugated Polyelectrolyte. Langmuir. 2005, 21, 10154–10159.
   PubMed Web of Science ®Google Scholar
• Yuan, Y.; Liu, J.; Liu, B. Conjugated‐Polyelectrolyte‐Based Polyprodrug: targeted and Image‐Guided Photodynamic and Chemotherapy with on‐Demand Drug Release upon Irradiation with a Single Light Source. Angew. Chem. 2014, 126, 7291–7296.
   Google Scholar
• Chilkoti, A.; Dreher, M. R.; Meyer, D. E.; Raucher, D. Targeted Drug Delivery by Thermally Responsive Polymers. Adv. Drug Deliv. Rev. 2002, 54, 613–630.
   PubMed Web of Science ®Google Scholar
• Meyer, D. E.; Kong, G. A.; Dewhirst, M. W.; Zalutsky, M. R.; Chilkoti, A. Targeting a Genetically Engineered Elastin-like Polypeptide to Solid Tumors by Local Hyperthermia. Cancer Res. 2001, 61, 1548–1554.
   PubMed Web of Science ®Google Scholar
• Liu, W.; Dreher, M. R.; Furgeson, D. Y.; Peixoto, K. V.; Yuan, H.; Zalutsky, M. R.; Chilkoti, A. Tumor Accumulation, Degradation and Pharmacokinetics of Elastin-like Polypeptides in Nude Mice. J. Control. Release. 2006, 116, 170–178.
   PubMed Web of Science ®Google Scholar
• Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Chilkoti, A. Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors. Cancer Res. 2007, 67, 4418–4424.
   PubMed Web of Science ®Google Scholar
• Furgeson, D. Y.; Dreher, M. R.; Chilkoti, A. Structural Optimization of a “Smart” Doxorubicin–Polypeptide Conjugate for Thermally Targeted Delivery to Solid Tumors. J. Control. Release. 2006, 110, 362–369.
   PubMed Web of Science ®Google Scholar
• Goodarzi, N.; Varshochian, R.; Kamalinia, G.; Atyabi, F.; Dinarvand, R. A Review of Polysaccharide Cytotoxic Drug Conjugates for Cancer Therapy. Carbohydr. Polymers. 2013, 92, 1280–1293.
   PubMed Web of Science ®Google Scholar
• Noguchi, Y.; Wu, J.; Duncan, R.; Strohalm, J.; Ulbrich, K.; Akaike, T.; Maeda, H. Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues. Japanese J. Cancer Res. 1998, 89, 307–314.
   PubMedGoogle Scholar
• Lee, C. C.; Cramer, A. T.; Szoka, F. C.; Fréchet, J. M. An Intramolecular Cyclization Reaction Is Responsible for the in Vivo Inefficacy and Apparent pH Insensitive Hydrolysis Kinetics of Hydrazone Carboxylate Derivatives of Doxorubicin. Bioconjugate Chem. 2006, 17, 1364–1368.
   PubMed Web of Science ®Google Scholar
• Kakinoki, A.; Kaneo, Y.; Ikeda, Y.; Tanaka, T.; Fujita, K. Synthesis of Poly (Vinyl Alcohol)–Doxorubicin Conjugates Containing Cis-Aconityl Acid-Cleavable Bond and Its Isomer Dependent Doxorubicin Release. Biol. Pharm. Bull. 2008, 31, 103–110.
   PubMed Web of Science ®Google Scholar
• Pechar, M.; Braunová, A.; Ulbrich, K.; Jelínková, M.; Ríhová, B. Poly (Ethylene Glycol)-Doxorubicin Conjugates with pH-Controlled Activation. J. bioactive and Compatible Polymers 2005, 20, 319–341.
   Web of Science ®Google Scholar
• Greenwald, R. B. PEG Drugs: An overview. J Control. Release. 2001, 74, 159–171.
   PubMed Web of Science ®Google Scholar
• Delplace, V.; Couvreur, P.; Nicolas, J. Recent trends in the design of anticancer polymer prodrug nanocarriers. Polymer Chem. 2014, 5, 1529–1544.
   Web of Science ®Google Scholar
• Chang, M.; Zhang, F.; Wei, T.; Zuo, T.; Guan, Y.; Lin, G.; Shao, W. Smart Linkers in Polymer–Drug Conjugates for Tumor-Targeted Delivery. J. Drug Target. 2016, 24, 475–491.
   PubMed Web of Science ®Google Scholar
• Ulbrich, K.; Šubr, V. Polymeric Anticancer Drugs with pH-Controlled Activation. Adv. Drug Deliv. Rev. 2004, 56, 1023–1050.
   PubMed Web of Science ®Google Scholar
• Boghaert, E. R.; Khandke, K. M.; Sridharan, L.; Dougher, M.; DiJoseph, J. F.; Kunz, A.; Hamann, P. R.; Moran, J.; Chaudhary, I.; Damle, N. K. Determination of Pharmacokinetic Values of Calicheamicin-Antibody Conjugates in Mice by Plasmon Resonance Analysis of Small (5 μl) Blood Samples. Cancer Chemother. Pharmacol. 2008, 61, 1027–1035.
   PubMed Web of Science ®Google Scholar
• Schafer, F. Q.; Buettner, G. R. Redox Environment of the Cell as Viewed Through the Redox State of the Glutathione Disulfide/Glutathione Couple. Free Radic Biol Med. 2001, 30, 1191–1212.
   PubMed Web of Science ®Google Scholar
• Gamcsik, M. P.; Kasibhatla, M. S.; Teeter, S. D.; Colvin, O. M. Glutathione Levels in Human Tumors. Biomarkers. 2012, 17, 671–691.
   PubMed Web of Science ®Google Scholar
• Meng, F.; Hennink, W. E.; Zhong, Z. Reduction-Sensitive Polymers and Bioconjugates for Biomedical Applications. Biomaterials. 2009, 30, 2180–2198.
   PubMed Web of Science ®Google Scholar
• Egeblad, M.; Werb, Z. New Functions for the Matrix Metalloproteinases in Cancer Progression. Nature Rev. Cancer. 2002, 2, 161.
   PubMed Web of Science ®Google Scholar
• Senter, P. D.; Sievers, E. L. The Discovery and Development of Brentuximabvedotin for Use in Relapsed Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma. Nature Biotechnol. 2012, 30, 631.
   PubMed Web of Science ®Google Scholar
• Chau, Y.; Tan, F. E.; Langer, R. Synthesis and Characterization of Dextran − Peptide − Methotrexate Conjugates for Tumor Targeting via Mediation by Matrix Metalloproteinase II and Matrix Metalloproteinase IX. Bioconjug. Chem. 2004, 15, 931–941.
   PubMed Web of Science ®Google Scholar
• Tong, R.; Kohane, D. S. Shedding Light on Nanomedicine. Wiley Interdiscip. Rev.2012, 4, 638–662.
   Google Scholar
• Tong, R.; Tang, L.; Ma, L.; Tu, C.; Baumgartner, R.; Cheng, J. Smart Chemistry in Polymeric Nanomedicine. Chemical Soc Rev. 2014, 43, 6982–7012.
   PubMed Web of Science ®Google Scholar
• Scott, L. C.; Yao, J. C.; Benson, A. B.; Thomas, A. L.; Falk, S.; Mena, R. R.; Picus, J.; Wright, J.; Mulcahy, M. F.; Ajani, J. A.; et al. A Phase II Study of Pegylated-Camptothecin (Pegamotecan) in the Treatment of Locally Advanced and Metastatic Gastric and Gastro-oesophageal Junction Adenocarcinoma. Cancer chemotherapy and pharmacology 2009, 63, 363–370.
   PubMed Web of Science ®Google Scholar
• Eldon, M. A.; Staschen, C. M.; Viegas, T.; Bentley, M. NKTR-102, a Novel PEGylated-Irinotecan Conjugate, Results in Sustained Tumor Growth Inhibition in Mouse Models of Human Colorectal and Lung Tumors that is Associated with Increased and Sustained Tumor SN38 exposure. Poster presented at the, 2007, 22–26.
   Google Scholar
• Zhao, H.; Rubio, B.; Sapra, P.; Wu, D.; Reddy, P.; Sai, P.; Martinez, A.; Gao, Y.; Lozanguiez, Y.; Longley, C.; et al. Novel Prodrugs of SN38 Using Multiarm Poly (Ethylene Glycol) Linkers. Bioconjug. Chem. 2008, 19, 849–859.
   PubMed Web of Science ®Google Scholar
• Choe, Y. H.; Greenwald, R. B.; Conover, C. D.; Zhao, H.; Longley, C. B.; Guan, S.; Zhao, Q.; Xia, J. PEG Prodrugs of 6-Mercaptopurine for Parenteral Administration Using Benzyl Elimination of Thiols. Oncol. Res. Featur. Preclin. Clin. Cancer Therap. 2004, 14, 455–468.
   Google Scholar
• Pasut, G.; Canal, F.; Dalla Via, L.; Arpicco, S.; Veronese, F. M.; Schiavon, O. Antitumoral Activity of PEG–Gemcitabine Prodrugs Targeted by Folic Acid. J. Control. Release. 2008, 127, 239–248.
   PubMed Web of Science ®Google Scholar
• Senevirathne, S. A.; Washington, K. E.; Biewer, M. C.; Stefan, M. C. PEG Based Anti-Cancer Drug Conjugated Prodrug Micelles for the Delivery of Anti-Cancer Agents. J. Mater. Chemistry B. 2016, 4, 360–370.
   PubMed Web of Science ®Google Scholar
• Bae, Y.; Jang, W. D.; Nishiyama, N.; Fukushima, S.; Kataoka, K. Multifunctional Polymeric Micelles with Folate-Mediated Cancer Cell Targeting and pH-Triggered Drug Releasing Properties for Active Intracellular Drug Delivery. Mol BioSyst 2005, 1, 242–250.
   PubMed Web of Science ®Google Scholar
• Yoo, H. S.; Lee, E. A.; Park, T. G. Doxorubicin-Conjugated Biodegradable Polymeric Micelles having Acid-Cleavable Linkages. J. Control. Release. 2002, 82, 17–27.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Li, S.; Han, Y.; Guan, J.; Chung, S.; Wang, C.; Li, D. Poly (Ethylene Glycol)–Polylactide Micelles for Cancer Therapy. Front. Pharmacol, 2018, 9, 202.
   PubMed Web of Science ®Google Scholar
• Vetvicka, D.; Hruby, M.; Hovorka, O.; Etrych, T.; Vetrik, M.; Kovar, L.; Kovar, M.; Ulbrich, K.; Rihova, B. Biological Evaluation of Polymeric Micelles with Covalently Bound Doxorubicin. Bioconjug. Chemistry. 2009, 20, 2090–2097.
   PubMed Web of Science ®Google Scholar
• Sui, B.; Xu, H.; Jin, J.; Gou, J.; Liu, J.; Tang, X.; Zhang, Y.; Xu, J.; Zhang, H.; Jin, X. Self-Assembled Micelles Composed of Doxorubicin Conjugated Y-Shaped PEG-Poly (Glutamic Acid) 2 Copolymers via Hydrazone Linkers. Molecules. 2014, 19, 11915–11932.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Li, Y.; Chen, X.; Wang, X.; Xu, X.; Liang, Q.; Hu, J.; Jing, X. Synthesis and Characterization of the Paclitaxel/MPEG-PLA Block Copolymer Conjugate. Biomaterials. 2005, 26, 2121–2128.
   PubMed Web of Science ®Google Scholar
• Yang, R.; Zhang, S.; Kong, D.; Gao, X.; Zhao, Y.; Wang, Z. Biodegradable Polymer-Curcumin Conjugate Micelles Enhance the Loading and Delivery of Low-Potency Curcumin. Pharmaceut. Res. 2012, 29, 3512–3525.
   PubMed Web of Science ®Google Scholar
• Jin, Q.; Mitschang, F.; Agarwal, S. Biocompatible Drug Delivery System for Photo-Triggered Controlled Release of 5-Fluorouracil. Biomacromolecules. 2011, 12, 3684–3691.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Kwon, G. S. Methotrexate esTers of Poly (Ethylene Oxide)-Block-Poly (2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release. Pharmaceut. Res. 2000, 17, 607–611.
   PubMed Web of Science ®Google Scholar
• Li, X.; Wang, M.; Liu, C.; Jing, X.; Huang, Y. TAT‐Modified Mixed Micelles as Biodegradable Targeting and Delivering System for Cancer Therapeutics. J. Appl. Polymer Sci. 2013, 130, 4598–4607.
   Web of Science ®Google Scholar
• Bae, Y.; Nishiyama, N.; Fukushima, S.; Koyama, H.; Yasuhiro, M.; Kataoka, K. Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor Efficacy. Bioconjugate Chem. 2005, 16, 122–130.
   PubMed Web of Science ®Google Scholar
• Svenson, S.; Wolfgang, M.; Hwang, J.; Ryan, J.; Eliasof, S. Preclinical to Clinical Development of the Novel Camptothecinnanopharmaceutical CRLX101. J. Control. Release. 2011, 153, 49–55.
   PubMed Web of Science ®Google Scholar
• Masayuki, Y.; Mizue, M.; Noriko, Y.; Teruo, O.; Yasuhisa, S.; Kazunori, K.; Shohei, I. Polymer Micelles as Novel Drug Carrier: Adriamycin-Conjugated Poly (Ethylene Glycol)-Poly (Aspartic Acid) Block Copolymer. J. Control. Release. 1990, 11, 269–278.
   Web of Science ®Google Scholar
• Yokoyama, M.; Miyauchi, M.; Yamada, N.; Okano, T.; Sakurai, Y.; Kataoka, K.; Inoue, S. Characterization and Anticancer Activity of the Micelle-Forming Polymeric Anticancer Drug Adriamycin-Conjugated Poly (Ethylene Glycol)-Poly (Aspartic Acid) Block Copolymer. Cancer Res. 1990, 50, 1693–1700.
   PubMed Web of Science ®Google Scholar
• Liu, J.; Liu, W.; Weitzhandler, I.; Bhattacharyya, J.; Li, X.; Wang, J.; Qi, Y.; Bhattacharjee, S.; Chilkoti, A. Ring‐Opening Polymerization of Prodrugs: A Versatile Approach to Prepare Well‐Defined Drug‐Loaded Nanoparticles. AngewandteChemie. 2015, 127, 1016–1020.
   Google Scholar
• Wang, Y.; Chen, L.; Tan, L.; Zhao, Q.; Luo, F.; Wei, Y.; Qian, Z. PEG–PCL Based Micelle Hydrogels as Oral Docetaxel Delivery Systems for Breast Cancer Therapy. Biomaterials. 2014, 35, 6972–6985.
   PubMed Web of Science ®Google Scholar
• Mikhail, A. S.; Allen, C. Poly (Ethylene Glycol)-b-Poly (ε-Caprolactone) Micelles Containing Chemically Conjugated and Physically Entrapped Docetaxel: Synthesis, Characterization, and the Influence of the Drug on Micelle Morphology. Biomacromolecules. 2010, 11, 1273–1280.
   PubMed Web of Science ®Google Scholar
• Shahin, M.; Lavasanifar, A. Novel Self-Associating Poly (Ethylene Oxide)-b-Poly (ɛ-Caprolactone) Based Drug Conjugates and Nano-Containers for Paclitaxel Delivery. Int. J. Pharm 2010, 389, 213–222.
   PubMed Web of Science ®Google Scholar
• Forrest, M. L.; Yáñez, J. A.; Remsberg, C. M.; Ohgami, Y.; Kwon, G. S.; Davies, N. M. Paclitaxel Prodrugs with Sustained Release and High Solubility in Poly (Ethylene Glycol)-b-Poly (ε-Caprolactone) Micelle Nanocarriers: Pharmacokinetic Disposition, Tolerability, and Cytotoxicity. Pharmaceut. Res. 2008, 25, 194–206.
   PubMed Web of Science ®Google Scholar
• Shahin, M.; Safaei-Nikouei, N.; Lavasanifar, A. Polymeric Micelles for pH-Responsive Delivery of Cisplatin. J. Drug Target. 2014, 22, 629–637.
   PubMed Web of Science ®Google Scholar
• Gharebaghi, F.; Dalali, N.; Ahmadi, E.; Danafar, H. Preparation of Wormlike Polymeric Nanoparticles Coated with Silica for Delivery of Methotrexate and Evaluation of Anticancer Activity Against MCF7 Cells. J. Biomater. Appl. 2017, 31, 1305–1316.
   PubMed Web of Science ®Google Scholar
• Asem, H.; Zhao, Y.; Ye, F.; Barrefelt, Å.; Abedi-Valugerdi, M.; El-Sayed, R.; El-Serafi, I.; Abu-Salah, K. M.; Hamm, J.; Muhammed, M.; et al. Biodistribution of Biodegradable Polymeric Nano-Carriers Loaded with Busulphan and Designed for Multimodal Imaging. J. Nanobiotechnol. 2016, 14, 82.
   PubMed Web of Science ®Google Scholar
• Dragojevic, S.; Ryu, J.; Raucher, D. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy. Molecules. 2015, 20, 21750–21769.
   PubMed Web of Science ®Google Scholar
• Vasey, P. A.; Duncan, R.; Kaye, S. B. Clinical phase I trial of PK1(HPMA Co-Polymer Doxorubicin) oral, 1995,31, S193.
   Google Scholar
• Vasey, P. A.; Kaye, S. B.; Morrison, R.; Twelves, C.; Wilson, P.; Duncan, R.; Thomson, A. H.; Murray, L. S.; Hilditch, T. E.; Murray, T.; et al.. Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl) Methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates. Clin. Cancer Res. 1999, 5, 83–94.
   PubMed Web of Science ®Google Scholar
• Yang, J.; Kopeček, J. The Light at the End of the Tunnel—Second Generation HPMA Conjugates for Cancer Treatment. Curr. Opin. Colloid Interface Sci. 2017, 31, 30–42.
   PubMed Web of Science ®Google Scholar
• Bissett, D.; Cassidy, J.; de Bono, J. S.; Muirhead, F.; Main, M.; Robson, L.; Fraier, D.; Magnè, M. L.; Pellizzoni, C.; Porro, M. G.; et al. Phase I and Pharmacokinetic (PK) Study of MAG-CPT (PNU 166148): A Polymeric Derivative of Camptothecin (CPT). British J. Cancer. 2004, 91, 50.
   PubMed Web of Science ®Google Scholar
• Terwogt, J. M. M.; ten BokkelHuinink, W. W.; Schellens, J. H.; Schot, M.; Mandjes, I. A.; Zurlo, M. G.; Rocchetti, M.; Rosing, H.; Koopman, F. J.; Beijnen, J. H. Phase I Clinical and Pharmacokinetic Study of PNU166945, A Novel Water-Soluble Polymer-Conjugated Prodrug of Paclitaxel. Anti Cancer Drugs. 2001, 12, 315–323.
   PubMed Web of Science ®Google Scholar
• Greco, F.; Vicent, M. J. Polymer-Drug Conjugates: Current Status and Future Trends. Front. Biosci. 2008, 13, 2744–2756.
   PubMed Web of Science ®Google Scholar
• Šubr, V.; Strohalm, J.; Hirano, T.; Ito, Y.; Ulbrich, K. Poly [N-(2-hydroxypropyl) methacrylamide] conjugates of methotrexate: synthesis and in vitro drug release. J. Control. Release. 1997, 49, 123–132.
   Web of Science ®Google Scholar
• United State Patent, Lee et al.. HPMA-Docetaxel conjugates and uses therefore. Patent no.: US 9,434,610 B2, September 6, 2016.
   Google Scholar
• Khare, V.; Kour, S.; Alam, N.; Dubey, R. D.; Saneja, A.; Koul, M.; Gupta, A. P.; Singh, D.; Singh, S. K.; Saxena, A. K.; Gupta, P. N. Synthesis, Characterization and Mechanistic-Insight into the Anti-Proliferative Potential of PLGA-Gemcitabine Conjugate. Int. J. Pharm. 2014, 470, 51–62.
   PubMed Web of Science ®Google Scholar
• Aggarwal, S.; Gupta, S.; Pabla, D.; Murthy, R. S. R. Gemcitabine-Loaded PLGA-PEG Immunonanoparticles for Targeted Chemotherapy of Pancreatic Cancer. Cancer nanotechnology 2013, 4, 145.
   PubMedGoogle Scholar
• Maleki, H.; Dorkoosh, F.; Adabi, M.; Khosravani, M.; Arzani, H.; Kamali, M. Methotrexate-Loaded PLGA Nanoparticles: Preparation, Characterization and their Cytotoxicity Effect on Human Glioblastoma U87MG Cells. Int. J. Med. Nano. Res. 2017, 4, 020.
   Google Scholar
• Singer, J. W.; Baker, B.; de Vries, P.; Kumar, A.; Shaffer, S.; Vawter, E.; Bolton, M.; Garzone, P. 2004. Poly-(l)-Glutamic Acid-Paclitaxel (CT-2103)[XYOTAX™], a Biodegradable Polymeric Drug Conjugate. In Polymer Drugs in the Clinical Stage. Springer: Boston, MA; pp 81–99
   Google Scholar
• United States Patent, Tsang et al. Reduction of Endotoxins from Polyanionic Polymer Conjugates. Patent no.: US 9,839,694 B2, December 12, 2017.
   Google Scholar
• Pun, S. H.; Hoffman, A. S. Polymer drug conjugate Application of biomaterials Section, 14, 1007–1017.
   Google Scholar
• Guan, H.; McGuire, M. J.; Li, S.; Brown, K. C. Peptide-Targeted Polyglutamic Acid Doxorubicin Conjugates for the Treatment of αvβ6-Positive Cancers. Bioconjug. Chemistry. 2008, 19, 1813–1821.
   PubMed Web of Science ®Google Scholar
• Luo, Y.; Bernshaw, N. J.; Lu, Z. R.; Kopecek, J.; Prestwich, G. D. Targeted Delivery of Doxorubicin by HPMA copolymer-hyaluronanbioconjugates. Pharmaceut. Res. 2002, 19, 396–402.
   PubMed Web of Science ®Google Scholar
• Auzenne, E.; Ghosh, S. C.; Khodadadian, M.; Rivera, B.; Farquhar, D.; Price, R. E.; Ravoori, M.; Kundra, V.; Freedman, R. S.; Klostergaard, J. Hyaluronic Acid-Paclitaxel: Antitumor Efficacy Against CD44 (+) Human Ovarian Carcinoma Xenografts. Neoplasia. 2007, 9, 479–486.
   PubMed Web of Science ®Google Scholar
• Luo, Y.; Ziebell, M. R.; Prestwich, G. D. A Hyaluronic Acid − Taxol Antitumor Bioconjugate Targeted to Cancer Cells. Biomacromolecules. 2000, 1, 208–218.
   PubMed Web of Science ®Google Scholar
• Bassi, P. F.; Volpe, A.; D'Agostino, D.; Palermo, G.; Renier, D.; Franchini, S.; Rosato, A.; Racioppi, M. Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guerin Refractory Carcinoma in situ of the Bladder: Results of a Phase I Study. J. Urol. 2011, 185, 445–449.
   PubMed Web of Science ®Google Scholar
• Cai, S.; Thati, S.; Bagby, T. R.; Diab, H. M.; Davies, N. M.; Cohen, M. S.; Forrest, M. L. Localized Doxorubicin Chemotherapy with a Biopolymericnanocarrier Improves Survival and Reduces Toxicity in Xenografts of Human Breast Cancer. J. Control. Release. 2010, 146, 212–218.
   PubMed Web of Science ®Google Scholar
• Fu, C.; Yang, R. M.; Wang, L.; Li, N. N.; Qi, M.; Xu, X. D.; Wei, X. H.; Jiang, X. Q.; Zhang, L. M. Surface Functionalization of Superparamagnetic Nanoparticles by an Acid-Liable Polysaccharide-Based Prodrug for Combinatorial Monitoring and Chemotherapy of Hepatocellular Carcinoma. RSC Adv. 2017, 7, 41919–41928.
   Web of Science ®Google Scholar
• Lee, H.; Lee, K.; Park, T. G. Hyaluronic Acid − Paclitaxel Conjugate Micelles: Synthesis, Characterization, and Antitumor Activity. Bioconjug. Chemistry. 2008, 19, 1319–1325.
   PubMed Web of Science ®Google Scholar
• Coradini, D.; Pellizzaro, C.; Miglierini, G.; Daidone, M. G.; Perbellini, A. Hyaluronic Acid as Drug Delivery for Sodium Butyrate: Improvement of the Anti‐Proliferative Activity on a Breast‐Cancer Cell Line. Int. J. Cancer. 1999, 81, 411–416.
   PubMed Web of Science ®Google Scholar
• Manju, S.; Sreenivasan, K. Enhanced Drug Loading on Magnetic Nanoparticles by Layer-by-Layer Assembly Using Drug Conjugates: Blood Compatibility Evaluation and Targeted Drug Delivery in Cancer Cells. Langmuir. 2011, 27, 14489–14496.
   PubMed Web of Science ®Google Scholar
• Manju, S.; Sreenivasan, K. Conjugation of Curcumin onto Hyaluronic Acid Enhances its Aqueous Solubility and Stability. J. Colloid Interface Sci. 2011, 359, 318–325.
   PubMed Web of Science ®Google Scholar
• Homma, A.; Sato, H.; Okamachi, A.; Emura, T.; Ishizawa, T.; Kato, T.; Matsuura, T.; Sato, S.; Tamura, T.; Higuchi, Y.; et al. Novel Hyaluronic Acid–Methotrexate Conjugates for Osteoarthritis Treatment. Bioorg. Med. Chemistry. 2009, 17, 4647–4656.
   PubMed Web of Science ®Google Scholar
• Li, Q.; Chen, Y.; Zhou, X.; Chen, D.; Li, Y.; Yang, J.; Zhu, X. Hyaluronic Acid–Methotrexate Conjugates Coated Magnetic Polydopamine Nanoparticles for Multimodal Imaging-Guided Multistage Targeted Chemo-Photothermal Therapy. Mol. Pharmaceut. 2018, 15, 4049–4062.
   PubMed Web of Science ®Google Scholar
• Okuno, S.; Harada, M.; Yano, T.; Yano, S.; Kiuchi, S.; Tsuda, N.; Sakamura, Y.; Imai, J.; Kawaguchi, T.; Tsujihara, K. Complete Regression of Xenografted Human Carcinomas by Camptothecin Analogue-Carboxymethyl Dextran Conjugate (T-0128). Cancer Res. 2000, 60, 2988–2995.
   PubMed Web of Science ®Google Scholar
• Danhauser-Riedl, S.; Hausmann, E.; Schick, H. D.; Bender, R.; Dietzfelbinger, H.; Rastetter, J.; Hanauske, A. R. Phase I Clinical and Pharmacokinetic Trial of Dextran Conjugated Doxorubicin (AD-70, DOX-OXD). Investig. New Drugs. 1993, 11, 187–195.
   PubMed Web of Science ®Google Scholar
• Dang, W.; Colvin, O. M.; Brem, H.; Saltzman, W. M. Covalent Coupling of Methotrexate to Dextran Enhances the Penetration of Cytotoxicity into a Tissue-Like Matrix. Cancer research 1994, 54, 1729–1735.
   PubMed Web of Science ®Google Scholar
• Nevozhay, D.; Budzynska, R.; Kanska, U.; Jagiello, M.; Omar, M. S.; Boratynski, J.; Opolski, A. Antitumor Properties and Toxicity of Dextran-Methotrexate Conjugates are Dependent on the Molecular Weight of the Carrier. Anticancer Res. 2006, 26, 1135–1143.
   PubMed Web of Science ®Google Scholar
• Chau, Y.; Dang, N. M.; Tan, F. E.; Langer, R. Investigation of Targeting Mechanism of New Dextran-Peptide-Methotrexate Conjugates Using Biodistribution Study in Matrix-Metalloproteinase-Overexpressing Tumor Xenograft Model. J. Pharm. Sci. 2006, 95, 542–551
   PubMed Web of Science ®Google Scholar
• Kato, Y.; Onishi, H.; Machida, Y. N-Succinyl-Chitosan as a Drug Carrier: Water-Insoluble and Water-Soluble Conjugates. Biomaterials. 2004, 25, 907–915.
   PubMed Web of Science ®Google Scholar
• Sato, M.; Onishi, H.; Kitano, M.; Machida, Y.; Nagai, T. Preparation and Drug Release Characteristics of the Conjugates of Mitomycin C with Glycol-Chitosan and N-Succinyl-Chitosan. Biol, Pharm. Bull. 1996, 19, 241–245.
   PubMed Web of Science ®Google Scholar
• Mukherjee, C. B.; Maji, R.; Dey, N. S.; Mukherjee, B.; Mondal, S. Int. J. Nanomed. Dovepress submit your manuscript| www.dovepress.com.
   Google Scholar
• Park, J. H.; Kwon, S.; Lee, M.; Chung, H.; Kim, J. H.; Kim, Y. S.; Park, R. W.; Kim, I. S.; Seo, S. B.; Kwon, I. C.; Jeong, S. Y. Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing Hydrophobic Moieties as Carriers for Doxorubicin: In vivo Biodistribution and Anti-Tumor Activity. Biomaterials. 2006, 27, 119–126.
   PubMed Web of Science ®Google Scholar
• Lee, E.; Lee, J.; Lee, I. H.; Yu, M.; Kim, H.; Chae, S. Y.; Jon, S. Conjugated Chitosan as a Novel Platform for ORAL Delivery of paclitaxel. J. Med. Chemistry. 2008, 51, 6442–6449.
   PubMed Web of Science ®Google Scholar
• Lee, E.; Kim, H.; Lee, I. H.; Jon, S. In vivo Antitumor Effects of Chitosan-Conjugated Docetaxel After Oral Administration. J. Control. Release. 2009, 140, 79–85.
   PubMed Web of Science ®Google Scholar
• Yuan, H.; Lu, L. J.; Du, Y. Z.; Hu, F. Q. Stearic Acid-g-Chitosan Polymeric Micelle for Oral Drug Delivery: In Vitro Transport and In Vivo Absorption. Mol. Pharmaceut. 2011, 8, 225–238.
   PubMed Web of Science ®Google Scholar
• Hou, L.; Fan, Y.; Yao, J.; Zhou, J.; Li, C.; Fang, Z.; Zhang, Q. Low Molecular Weight Heparin-All-Trans-Retinoid Acid Conjugate as a Drug Carrier for Combination Cancer Chemotherapy of Paclitaxel and All-Trans-Retinoid Acid. Carbohydr. Polym. 2011, 86, 1157–1166.
   Web of Science ®Google Scholar
• Park, I. K.; Kim, Y. J.; Tran, T. H.; Huh, K. M.; Lee, Y. K. Water-Soluble Heparin–PTX Conjugates for Cancer Targeting. Polymer. 2010, 51, 3387–3393.
   Web of Science ®Google Scholar
• Wang, Y.; Xin, D.; Liu, K.; Zhu, M.; Xiang, J. Heparin − paclitaxel Conjugates as Drug Delivery System: Synthesis, Self-Assembly Property, Drug Release, and Antitumor Activity. Bioconjug. Chemistry. 2009, 20, 2214–2221.
   PubMed Web of Science ®Google Scholar
• Cheng, J.; Khin, K. T.; Jensen, G. S.; Liu, A.; Davis, M. E. Synthesis of Linear, β-Cyclodextrin-Based Polymers and their Camptothecin Conjugates. Bioconjug. Chemistry. 2003, 14, 1007–1017.
   PubMed Web of Science ®Google Scholar
• Davis, M. E. Design and Development of IT-101, a Cyclodextrin-Containing Polymer Conjugate of Camptothecin. Adv. Drug Deliv. Rev. 2009, 61, 1189–1192.
   PubMed Web of Science ®Google Scholar
• Al-Shamkhani, A.; Duncan, R. Synthesis, Controlled Release Properties and Antitumour Activity of Alginate-Cis-Aconityl-Daunomycin Conjugates. Int. J. Pharm. 1995, 122, 107–119.
   Web of Science ®Google Scholar
• Zhang, H.; Li, F.; Yi, J.; Gu, C.; Fan, L.; Qiao, Y.; Tao, Y.; Cheng, C.; Wu, H. Folate-Decorated Maleilated Pullulan–Doxorubicin Conjugate for Active Tumor-Targeted Drug Delivery. Eur. J. Pharm. Sci. 2011, 42, 517–526.
   PubMed Web of Science ®Google Scholar
• Luo, Q.; Wang, P.; Miao, Y.; He, H.; Tang, X. A Novel 5-Fluorouracil Prodrug Using Hydroxyethyl Starch as a Macromolecular Carrier for Sustained Release. Carbohydr. Polym. 2012, 87, 2642–2647.
   Web of Science ®Google Scholar
• Banerjee, S. S.; Aher, N.; Patil, R.; Khandare, J. Poly (Ethylene Glycol)-Prodrug Conjugates: Concept, Design, and Applications. J. Drug Deliv. 2012, 2012, 1.
   Google Scholar
• Duncan, R. Polymer Conjugates as Anticancer Nanomedicines. Nature Rev. Cancer. 2006, 6, 688.
   PubMed Web of Science ®Google Scholar
• Hu, X.; Liu, S.; Huang, Y.; Chen, X.; Jing, X. Biodegradable Block Copolymer-Doxorubicin Conjugates via Different Linkages: preparation, Characterization, and in Vitro Evaluation. Biomacromolecules. 2016, 11, 2094–2102.
   Web of Science ®Google Scholar